Clinical Trial Update: Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer

View source ↗

Summary

A clinical trial update reports that hepatic radiofrequency ablation increases T cell infiltration and PD-L1 expression in primary colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Colorectal Cancer | Status: COMPLETED